4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
3.42
0.22 (6.87%)
At close: May 16, 2025, 3:59 PM
3.42
-0.15%
After-hours: May 16, 2025, 05:27 PM EDT
6.87% (1D)
| Bid | 3.05 |
| Market Cap | 158.66M |
| Revenue (ttm) | 9K |
| Net Income (ttm) | -176.44M |
| EPS (ttm) | -2.98 |
| PE Ratio (ttm) | -1.15 |
| Forward PE | -0.84 |
| Analyst | Buy |
| Ask | 3.98 |
| Volume | 364,060 |
| Avg. Volume (20D) | 675,282 |
| Open | 3.25 |
| Previous Close | 3.20 |
| Day's Range | 3.19 - 3.48 |
| 52-Week Range | 2.23 - 28.93 |
| Beta | 2.86 |
About FDMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FDMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FDMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-13.91%
4D Molecular Therapeutics shares are trading lower...
Unlock content with
Pro Subscription
4 months ago
-13.77%
4D Molecular Therapeutics shares are trading lower after Leerink Partners and Morgan Stanley cut their respective price targets on the stock.
